Tower Research Capital (TRC)’s Invesco Bloomberg Analyst Rating Improvers ETF UPGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$683K Sell
9,373
-17,205
-65% -$1.32M 0.02% 721
2025
Q4
$1.97M Buy
26,578
+12,267
+86% +$912K 0.05% 331
2025
Q3
$1.07M Sell
14,311
-1,536
-10% -$113K 0.03% 490
2025
Q2
$1.12M Sell
15,847
-4,809
-23% -$331K 0.03% 499
2025
Q1
$1.45M Buy
20,656
+2,814
+16% +$199K 0.04% 377
2024
Q4
$1.23M Sell
17,842
-692
-4% -$50.1K 0.02% 537
2024
Q3
$1.33M Sell
18,534
-278
-1% -$19K 0.04% 409
2024
Q2
$1.23M Sell
18,812
-2,902
-13% -$189K 0.02% 641
2024
Q1
$1.44M Buy
21,714
+8,717
+67% +$548K 0.03% 380
2023
Q4
$803K Buy
12,997
+6,620
+104% +$372K 0.01% 1014
2023
Q3
$355K Sell
6,377
-8,956
-58% -$523K 0.01% 1075
2023
Q2
$892K Buy
15,333
+9,196
+150% +$508K 0.03% 578
2023
Q1
$340K Sell
6,137
-8,442
-58% -$483K 0.01% 1066
2022
Q4
$790K Buy
14,579
+7,211
+98% +$391K 0.03% 474
2022
Q3
$373K Sell
7,368
-11,717
-61% -$653K 0.01% 1377
2022
Q2
$976K Buy
19,085
+1,295
+7% +$72.2K 0.02% 704
2022
Q1
$1.09M Buy
17,790
+392
+2% +$23.5K 0.01% 758
2021
Q4
$1.09M Sell
17,398
-2,887
-14% -$181K 0.02% 647
2021
Q3
$1.22M Buy
20,285
+5,196
+34% +$311K 0.03% 447
2021
Q2
$928K Sell
15,089
-3,780
-20% -$229K 0.02% 716
2021
Q1
$1.09M Buy
18,869
+5,044
+36% +$282K 0.02% 735
2020
Q4
$704K Buy
13,825
+8,435
+156% +$387K 0.02% 739
2020
Q3
$215K Sell
5,390
-32,325
-86% -$1.3M ﹤0.01% 2512
2020
Q2
$1.47M Buy
37,715
+2,888
+8% +$100K 0.06% 331
2020
Q1
$998K Buy
34,827
+17,730
+104% +$734K 0.06% 226
2019
Q4
$822K Buy
+17,097
New +$759K 0.07% 153
2017
Q2
Sell
-633
Closed -$25K 3549
2017
Q1
$25K Buy
+633
New +$25K ﹤0.01% 1158
2016
Q2
Sell
-146
Closed -$5K 5065
2016
Q1
$5K Sell
146
-938
-87% -$28.3K ﹤0.01% 2748
2015
Q4
$35K Buy
1,084
+894
+471% +$30.1K 0.01% 764
2015
Q3
$6K Buy
+190
New +$6.63K ﹤0.01% 2703

Other funds holding UPGD

Tower Research Capital (TRC)'s UPGD Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) stake by 65% in Q1 2026, selling an estimated $1.32M and leaving 9,373 shares worth $683K. The position accounts for 0.02% of the portfolio, ranked #721.

Tower Research Capital (TRC) first reported a position in UPGD in Q3 2015 and has held it in 30 quarters since. The position peaked at $1.97M in Q4 2025. 31 funds tracked by Wall St. Rank hold UPGD as of Q1 2026.

  • Tower Research Capital (TRC) held 9,373 shares of Invesco Bloomberg Analyst Rating Improvers ETF worth $683K as of Q1 2026.
  • Tower Research Capital (TRC) sold 17,205 Invesco Bloomberg Analyst Rating Improvers ETF shares in Q1 2026, an estimated $1.32M.
  • Invesco Bloomberg Analyst Rating Improvers ETF made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #721 holding.
  • Tower Research Capital (TRC) first reported a position in Invesco Bloomberg Analyst Rating Improvers ETF in Q3 2015 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Invesco Bloomberg Analyst Rating Improvers ETF position peaked at $1.97M in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Invesco Bloomberg Analyst Rating Improvers ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.